Kelly O'Neill, Author at Rheumatoid Arthritis Warrior | Page 39 of 118

Aftermath of the FDA Vote on Pfizer’s RA JAK Inhibitor, Tofacitinib

May 15, 2012May 14, 2018 Kelly O'Neill 44 Comments Rheum Disease in the Media, Rheumatoid Arthritis awareness, Woman's Day problem, XELJANZ-tofacitinib-JAK

After the tofacitinib FDA hearing, the votes are in, false perceptions persist, and patients still need relief. Some estimate that tofacitinib could be approved by the US FDA within a few months after mixed votes and mostly inaccurate press reports. It’s fitting this discussion takes place as rawarrior.com begins its fourth year of reporting the patient...Continue reading 44 Comments » Read more

Leaving It All on the Field: Not the Safest Choice But Maybe Best

May 14, 2012May 14, 2018 Kelly O'Neill 12 Comments Living with chronic illness like RA, Patient advocacy, Professional patient

Sightseeing, small steps, and sleep I’ve spent most of the last 3 weeks lying down with ice on my neck, or taking extra meds for the back spasms. The night before the FDA tofacitinib hearing, my back got so bad that I was about 90% certain that I would not be able to attend. My little...Continue reading 12 Comments » Read more

FDA Arthritis Advisory Committee Hearing for Pfizer’s RA JAK: Tofacitinb

May 9, 2012April 20, 2019 Kelly O'Neill 27 Comments Living with chronic illness like RA, XELJANZ-tofacitinib-JAK

Advisory Committee hearing feed link My daughter Katie Beth and I are in Washington, DC for the final FDA Arthritis Advisory Committee (AAC) hearing about Pfizer’s JAK, tofacitinib. Early in the morning, Katie Beth and I will be en route to the meeting. The AAC meeting will be broadcast online with a live feed. We’ve been told...Continue reading 27 Comments » Read more

Attending an FDA Hearing for Pfizer’s JAK: Tofacitinib CP-690550

May 6, 2012April 20, 2019 Kelly O'Neill 28 Comments Rheumatoid arthritis treatment, XELJANZ-tofacitinib-JAK

Three years ago, one of the first friends I made through my blog was Angie. She got into a Pfizer clinical trial for tofacitinib (then called tasocitinib). She sent me some info about the trial, but my rheum doc wasn’t interested and I didn’t pursue it. The current excitement about Pfizer’s tofacitinib Tofacitinib is an oral medication...Continue reading 28 Comments » Read more

Consumer Reports’ Absurd Best Buy Rheumatoid Arthritis Drug List

May 4, 2012May 15, 2018 Kelly O'Neill 47 Comments Biologics for RA, Rheum Disease in the Media, Rheumatoid Arthritis awareness

RESPONSE TO Consumer Reports Health Best Buy Drugs; Evaluating Prescription Drugs Used to Treat the Symptoms of Rheumatoid Arthritis: The Biologics Warrior to Washington: Next week, I’m going to D.C. to make an oral presentation to the “Arthritis Advisory Committee” at a hearing about a new Rheumatoid Arthritis treatment, tofacitinib. I want you to know why...Continue reading 47 Comments » Read more

Game On! 2 of You Will Win 6 Trudeau Stressless Kitchen Tools

May 2, 2012May 15, 2018 Kelly O'Neill 3 Comments Doing Projects with RA, Rheumatoid arthritis disability

RA Warrior has never done product reviews, but I said yes to this easy contest because I get to give away sets of six kitchen tools to 2 of my wonderful readers. So, play our game to see if you can win! You can always give the tools away if you don’t need them. The game...Continue reading 3 Comments » Read more

Significant Numbers of RA Patients Don’t Receive Recommended Care

April 30, 2012May 15, 2018 Kelly O'Neill 24 Comments American College of Rheumatology, Comprehensive RA Care, Rheumatoid arthritis treatment

Understanding the reality of the disease is only half the battle We are making progress. Although there’s still a long way to go, patients are playing a part of advancements toward more complete understanding of Rheumatoid Arthritis as a disease. We might suppose that once RA is more widely understood to be a systemic disease, it...Continue reading 24 Comments » Read more